CLINLIFE
LIVE

Serial Number

79360372

Owner

Clariness GmbH

Attorney

Gabrielle A. Holley

Filing Date

Oct 24, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CLINLIFE Trademark

Serial Number: 79360372 • Registration: 7423869

CLINLIFE is a trademark filed by Clariness GmbH on October 24, 2022. The trademark is classified under Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Clariness GmbH (2 trademarks)

Schillerstr. 44

Entity Type: 99

Trademark Details

Filing Date

October 24, 2022

Registration Date

June 25, 2024

Published for Opposition

April 9, 2024

Goods & Services

Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; provision of information and data relating to medical and veterinary research and development

Providing information relating to medical services; providing medical information in the healthcare sector

Transmission of information by electronic communications networks, namely, forwarding of information, in particular on scientific or clinical studies and diseases, via electronic communication media, in particular via Internet platforms, e-mail newsletters and mobile phone messages; provision of access to databases in the nature of interactive electronic platforms for communication and exchange of data and information of all kinds, in particular via chat lines, chat rooms and Internet forums; e-mail forwarding services; web messaging in the nature of forwarding of messages to Internet addresses; provision of user access to computer programmes in data networks

Recruitment and placement of participants in scientific and clinical studies with pharmaceutical preparations; presentation of goods and services for third parties, in particular on the internet for retail purposes; managed business services, namely, arranging contracts for services for third parties; advertising on the internet for third parties; all aforementioned services, in particular in the medical and pharmaceutical field; wholesale and retail store services featuring medical and pharmaceutical goods and body and beauty care products; collection of data for business purposes, in particular data on scientific or clinical studies and diseases; provision of business statistical information relating to medical matters

Educational services, namely, providing classes, seminars, and workshops in the medical, pharmaceutical and clinical trial fields; training services in the medical, pharmaceutical and clinical trial fields; entertainment in the nature of providing ongoing online programs in the medical, pharmaceutical and clinical trial fields; organizing community sporting and cultural activities, in particular in the field of health; publication of printed matter and electronic publications containing information, in particular on scientific and clinical studies with pharmaceutical preparations and diseases; distribution of radio and television programmes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 15, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 9, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 9, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 25, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 25, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 25, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 10, 2024 OPNR
NOTIFICATION PROCESSED BY IB
Apr 15, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 9, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 20, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 7, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2024 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 1, 2023 RFCS
REFUSAL PROCESSED BY MPU
Sep 1, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 12, 2023 RFCR
NON-FINAL ACTION WRITTEN
Aug 11, 2023 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 18, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 14, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 12, 2023 REPR